IP Verse

Boult Wade Tennant competitive analysis

Explore the latest publications and patents granted to Boult Wade Tennant, showcasing their recent innovations and technological advancements.

Explore patent oppositions filed by Boult Wade Tennant against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3570885	Method Of Treating Or Ameliorating Metabolic Disorders Using Glp-1 Receptor Agonists Conjugated To Antagonists For Gastric Inhibitory Peptide Receptor (Gipr)	AMGEN	Jun 16, 2025
EP3684786	Mutated Glycoprotein Of Vesicular Stomatitis Virus	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS	May 14, 2025
EP3506931	Methods For Preventing Or Treating Allergy By Administering An Il-4R Antagonist	REGENERON PHARMACEUTICALS	Apr 30, 2025
EP3889181	Methods For Treating Atopic Dermatitis By Administering An Il-4R Antagonist	REGENERON PHARMACEUTICALS	Jan 24, 2025
EP3820625	Device For Dispensing A Fluid Product, And Method For Filling And For Plugging Same	APTAR FRANCE	Dec 12, 2024
EP3818078	Methods Of Producing Recombinant Proteins	BRISTOL MYERS SQUIBB	Nov 26, 2024
EP3585402	Compositions, Articles Of Manufacture And Methods Related To Dosing In Cell Therapy	JUNO THERAPEUTICS	Nov 12, 2024
EP3515465	Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R Inhibitor	REGENERON PHARMACEUTICALS	Nov 6, 2024
EP3973987	Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist	REGENERON PHARMACEUTICALS	Oct 10, 2024
EP3703818	Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist	REGENERON PHARMACEUTICALS	Jul 30, 2024

Discover the latest PTAB cases involving Boult Wade Tennant, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Boult Wade Tennant with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
BOULT WADE TENNANT	52	-	-	-	Highly Aggressive
DANA FARBER CANCER INSTITUTE	-	14	3	1	Defensive
REGENERON PHARMACEUTICALS	38	93	9	30	Balanced
SANOFI BIOTECHNOLOGY	-	50	-	-	Non-Active